Verdiva Bio: Funding, Investors & Team (Sep 2026)
Verdiva Bio is a company developing innovative therapies to enhance outcomes for individuals with obesity, cardiometabolic conditions, and related issues by offering more user-friendly treatment choices.
Verdiva Bio has raised $411M across 1 funding round on record, the most recent a Series A of $411M announced in Jan 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Verdiva Bio Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Verdiva Bio Funding Rounds
Verdiva Bio Founders and Leadership Team
Contact details for the Verdiva Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Verdiva Bio Funding Compared to Other Biotechnology Startups
Verdiva Bio's latest round of $411M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Verdiva Bio in Biotechnology and London
Companies Similar to Verdiva Bio
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Verdiva Bio Funding FAQs
What does Verdiva Bio do?
Verdiva Bio is a company developing innovative therapies to enhance outcomes for individuals with obesity, cardiometabolic conditions, and related issues by offering more user-friendly treatment choices.
How much funding has Verdiva Bio raised?
Verdiva Bio has raised $411M across 1 round on record. The most recent is a Series A of $411M announced in Jan 2025.
When did Verdiva Bio last raise funding?
Verdiva Bio's most recent funding round on record is a Series A of $411M, announced in Jan 2025.
Who founded Verdiva Bio?
FundedIQ lists Tapan Maniar (Founder) at Verdiva Bio.
Where is Verdiva Bio headquartered?
Verdiva Bio is based in London, England, United Kingdom.
How many employees does Verdiva Bio have?
Verdiva Bio is in the 11-50 employee band.
How does Verdiva Bio's funding compare to other Biotechnology startups?
Verdiva Bio's latest round of $411M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Verdiva Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Verdiva Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.